Does white matter structure or hippocampal volume mediate associations between cortisol and cognitive ageing?  by Cox, Simon R. et al.
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a b s t r a c t
Elevated glucocorticoid (GC) levels putatively damage speciﬁc brain regions, which in turn may accel-
erate cognitive ageing. However, many studies are cross-sectional or have relatively short follow-up
periods, making it difﬁcult to relate GCs directly to changes in cognitive ability with increasing age.
Moreover, studies combining endocrine, MRI and cognitive variables are scarce, measurement methods
vary considerably, and formal tests of the underlying causal hypothesis (cortisol→brain→ cognition) are
absent. In this study, 90 men, aged 73 years, provided measures of ﬂuid intelligence, processing speed
and memory, diurnal and reactive salivary cortisol and two measures of white matter (WM) structure
(WM hyperintensity volume from structural MRI and mean diffusivity averaged across 12 major tracts
from diffusion tensor MRI), hippocampal volume, and also cognitive ability at age 11. We tested whether
negative relationships between cognitive ageing differences (over more than 60 years) and salivary cor-
tisol were signiﬁcantly mediated by WM and hippocampal volume. Signiﬁcant associations between
reactive cortisol at 73 and cognitive ageing differences between 11 and 73 (r=−.28 to −.36, p< .05)
were partially mediated by both WM structural measures, but not hippocampal volume. Cortisol-WM
relationshipsweremodest, aswas the degree towhichWMstructure attenuated cortisol–cognition asso-
ciations (<15%). These data support the hypothesis that GCs contribute to cognitive ageing differences
from childhood to the early 70s, partly via brain WM structure.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license. Introduction
Exposure to elevated glucocorticoid (GC) levels is hypothesised
o have deleterious effects on brain structure (or speciﬁc regions
r tissue types thereof), which negatively affect cognitive func-
ion (Landﬁeld et al., 2007; Sapolsky et al., 1986). GCs (cortisol
n humans) exhibit a complex diurnal pattern and also a phasic
esponse to psychological and physical challenge. Increasing age is
ssociatedwith altered diurnal and reactive proﬁles of GCs (cortisol
n humans; Heaney et al., 2010; Otte et al., 2005) as well as average
eclines in brain structure and cognitive function. Several stud-
∗ Corresponding author at: Department of Psychology, 7 George Square, Edin-
urgh EH8 9JZ, UK. Fax: +44 (0)131 651 1771.
E-mail address: simon.cox@ed.ac.uk (S.R. Cox).
ttp://dx.doi.org/10.1016/j.psyneuen.2015.08.005
306-4530/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
ies usingmoderate-to-large sample sizes suggest that impairments
in domains of processing speed, memory and global cognition are
associated with higher diurnal and reactive cortisol measures in
older adults (97≤n≤1154; Comijs et al., 2010; Gerritsen et al.,
2009; Kuningas et al., 2007; Lee et al., 2007; MacLullich et al.,
2005). Separately, other studies suggest that cognitive ageing may
bemediated via brain structure (discussed below), yet, studieswith
all three types of data—cortisol, brain structure, and cognition—are
rare, and no formal tests of mediation have been undertaken
to directly test this central three-component hypothesis. Synthe-
sis of ﬁndings is hampered by the variety of cognitive measures
employed, and diurnal and reactive cortisol (e.g. in response to a
psychological stressor) are seldom reported together. The absence
of information about prior cognitive ability in the majority of pre-
vious studies also makes cross-sectional analyses of GCs, brain
and behaviour difﬁcult to interpret because the overarching causal
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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ypothesis posits a change of cognition over time, dependent upon
C levels.
With respect to possible mediators of cortisol-cognition rela-
ionships, the hippocampus is one putative neural substrate of
hese effects. The initial hypothesis of GC-induced hippocampal
ell death has been moderated by evidence of reversible dendritic
trophy in the rodent hippocampus (Conrad, 2009; McEwen and
ianaros, 2010) and GC-induced impairments in memory tasks
Dachir et al., 1993; Sousa et al., 2000). However, evidence of
igniﬁcant associations between cortisol levels and hippocampal
olume amonghealthy older humans is limited. Lupien et al. (1998)
eported that 11 individuals with increasing 24h cortisol over
years had decreasing hippocampal volumes and concomitant
eclines in memory. Subsequent studies in larger samples report
o signiﬁcant relationship between cortisol and hippocampalmea-
ures in non-pathological ageing (Coluccia et al., 2008; Gold et al.,
005; Kremen et al., 2010a; MacLullich et al., 2005, 2006, 2012).
There is also evidence that the brain’s white matter (WM)
ay be susceptible to elevated GC effects. WM is signiﬁcant
ecause of its relationship with cognitive ability (Filley, 2010;
enke et al., 2012) and because it supports efﬁcient informa-
ion transfer between brain regions involved in supra-HPA axis
egulation (Ulrich-Lai and Herman, 2009). There is evidence
hat elevated GCs alter cerebral white matter microstructure.
n rodents, administering a GC receptor agonist following brain
esion impaired axonal sprouting in a dose-dependent manner
hen compared to controls (Scheff and Cotman, 1982; Scheff and
eKosky, 1983). Elevated GCs and stress inhibit the proliferation
f astrocytes and oligodendrocytes (Alonso, 2000; Miyata et al.,
011; Rajkowska and Miguel-Hidalgo, 2007), suggesting that GCs
ay play a role in hindering oligodendrocyte-mediated axonal
emyelination. In humans, Cushings syndrome patients reportedly
xhibit widespread loss of white matter integrity and predomi-
ant demyelination (Pires et al., 2015), and thesedifferences persist
any years after remission (van der Werff et al., 2014). In healthy
lder adults, higher eveningcortisolwasassociatedwith loweresti-
ates of periventricular WM structure (Macritchie et al., 2013). In
he same older males as in the present study, we reported that
levated reactive cortisol at the start or end of cognitive testing
as associated with lower WM structural estimates (Cox et al.,
015). In the current study, we therefore, expand the analyses to
eport novel associations between cortisol and cognitive ability,
nd also novel associations between cortisol and hippocampal vol-
me. We then use mediation analysis to test the hypothesis that
hese cortisol–brain associations might have ramiﬁcations for cog-
itive ageing differences.
In summary, cross-sectional bivariate analyses have been the
ainstay of studies which test the hypothesis that elevated corti-
ol has deleterious effects on the brain and cognitive functioning.
et there remain no attempts to test whether cortisol–cognition
elationships are mediated by poorer brain structure. This may be
ue to a lack of studies that collect all three requisite domains
f data, or to the ﬁle-drawer effect in previous studies with all
hree types of data (i.e. no signiﬁcant 3-way associations—required
or mediation analysis—were found). This, in turn, may be due to
he focus on hippocampal measures whereas, in fact, other brain
ndices (such as WM measures) might be just as – or more – per-
inent to cognitive performance among healthy older individuals.
inally, inferring whether cortisol affects cognitive decline in old
ge requires knowledge of how a subject is performing now, rela-
ive to theirprior ability. This information is absent inmanyexisting
C studies which use cross-sectional cognitive indices, and longi-
udinal cognitive data are few, spanning only 6 years or less. In
he current study, we examine a group of 90 older males who
ave provided both diurnal and reactive salivary cortisol mea-
ures, hippocampal volumeandmeasuresofwhitematter structureinology 62 (2015) 129–137
measured at age 73 years, and cognitive ability scores obtained
at ages 11 and 73 years. The association between childhood and
older-age cognitive ability measured in this way typically ranges
between .60 to .70 (reviewed in Deary, 2014), indicating that intel-
ligence between youth and old age is remarkably stable throughout
the lifecourse. Importantly, however, the association is not per-
fect, allowing investigations into which factors might be related to
cognitive ageing differences. In this instance, these data afford a
rare opportunity to test the hypothesis that elevated cortisol levels
are associated with negative cognitive change (over more than 60
years) vianegative relationshipsbetweencortisol andhippocampal
volume or WM structure.
2. Material and methods
2.1. Participants
Theparticipantswere90older community-dwellingmales from
the Lothian Birth Cohort 1936 (LBC1936). The members of this
cohort were born in 1936 and sat a valid IQ-type test (Moray House
Test No. 12; MHT) at school in Scotland in June 1947 at an average
age of 11 years. At around 70 years of age, 1091 surviving, healthy,
community-dwelling residents in the Edinburgh and Lothians area,
most of whom had taken this test in 1947, were recruited as the
LBC1936 and underwent a series of cognitive and physical tests
(Deary et al., 2007). Three years later, 866 returned for a second
follow-up wave of cognitive testing and an MRI brain scan (Deary
et al., 2012; Wardlaw et al., 2011).
From this second wave of LBC1936 testing, male participants
were selected on the following criteria: a score of 24 out of 30
or greater on the MMSE (Folstein et al., 1975), a score less than
11 out of 21 on the depression facet of the Hospital Anxiety and
Depression Scale (Snaith, 2003), a complete MRI scan, not taking
any antidepressant or glucocorticoid medication, free from diag-
nosis of neurodegenerative disorders and no history of serious
neurological event (brain scans were examined by a consultant
neuroradiologist; JMW). Of 118 potential participants, 90 agreed
to take part. These participants were of mean age 73.10 (SD 0.40)
years when they sat a battery of cognitive tests (see Section 2.3).
At MRI scanning, they had a mean age of 73.30 (SD 0.37) years.
They were invited to attend an appointment in a novel (for them)
location (Department of Psychology, University of Edinburgh) to
attend a cognitive testing session during which salivary cortisol
was collected at the start and end of the testing session; diurnal
salivary cortisol was sampled on waking and at 10pm on a separate
weekday (see Section2.2). Salivary cortisol sampling tookplace just
over one year after MRI acquisition (mean 431.42 days, SD 103.62).
Written informed consent was obtained from each participant and
the study was conducted in compliance with departmental guide-
lines on participant testing and the Declaration of Helsinki. Ethical
approval was gained from NHS Lothian Research Ethics Committee
(NREC:07/MRE10/58) and the Philosophy, Psychology and Lan-
guage Sciences Research Ethics Committee at the University of
Edinburgh.
2.2. Cortisol
Salivette devices (Sarstedt, Numbrecht, Germany) were used
and samples stored at −80 ◦C following collection. Assayswere car-
riedoutbyDresdenLabServiceGmbH inaccordancewithaMaterial
Transfer Agreement. All measures are reported in nmol/l. Reactive
cortisol was measured at the start and end of a cognitive testing
appointment (referred to as STARTandEND, respectively; Cox et al.,
2015). Efforts were made to normalise the testing time for each
participant, which took take place three hours following waking
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n that day (Mean=3h 16mins, SD=51mins). Diurnal measures
ere taken on a separate weekday on natural waking and 10pm at
ight (WAKING and EVENING, respectively). REACTIVE SLOPE and
IURNAL SLOPE were calculated by subtracting the earlier (WAK-
NG or START) from the later measure (EVENING or END). Thus, a
ecreasing slope is denoted by a negative value.
.3. Cognitive tests
Age 11 cognitive ability was measured using participants’ total
HT score, administered in June 1947 as part of the ScottishMental
urvey. The test included items on reasoning, word classiﬁcation
nd other verbal, spatial and arithmetical items with a 45min time
imit allowed. The total score was concurrently validated against
he Terman–Merrill revision of the Binet Scales (Scottish Council
or Research in Education, 1932).
At age 73, three cognitive domainsweremeasured from the ﬁrst
nrotated component of three separate principal component anal-
ses (PCAs), reﬂecting prior demonstrations of ﬂuid intelligence (or
f) as hierarchically superordinate and non-orthogonal to the cog-
itive domains of processing speed and memory, each of which
re affected by increasing age (e.g. Deary, 2001; Salthouse, 2004).
luid intelligence (or gf) was derived from Matrix Reasoning, Block
esign, Digit Span Backward and Letter–Number Sequencing sub-
ests from the Wechsler Adult Intelligence Scale, 3rd UK Edition
WAIS-IIIUK; Wechsler, 1998a), accounting for 55.79% of the vari-
nce. Processing speed used the Digit–Symbol Coding and Symbol
earch tests from the WAIS III-UK, two measures from a bespoke
eaction time box (Simple and Four-Choice reaction time; Deary
t al., 2001) and one visual inspection time task on a computer
Deary et al., 2004), and accounted for 52.47%of the variance.Mem-
ry was measured using Logical Memory, Verbal Paired Associates,
etter–Number Sequencing, Spatial Span and Backward Digit Span
ubtests from the Wechsler Memory Scale 3rd UK Edition (WMS
II-UK; Wechsler, 1998b), accounting for 53.79% of the variance.
These cognitive domain scores at age 73 were corrected for age
1 cognitive ability using linear regression in which the residual
alue represents the deviation in age 73 cognitive ability (gf, Speed,
emory) from that predicted by cognitive ability at age 11. This
ielded the residual scores (gfR, SpeedR and MemoryR), where a
egative value indicates a decline from initial ability in cognition
elative to others in the sample.
.4. MRI acquisition
All MRI data were obtained from a GE Signa Horizon HDxt 1.5
clinical scanner (General Electric, Milwaukee, WI, USA) using
self-shielding gradient set with maximum gradient strength of
3 m/Tm, and an 8-channel phased-array head coil. The full MRI
rotocol has been described in detail elsewhere (Wardlaw et al.,
011). Brieﬂy, image acquisition comprised whole-brain structural
2-, T2*- and ﬂuid-attenuated inversion recovery (FLAIR)-weighted
xial scans, and a high-resolution 3D T1-weighted (T1W) volume
equence (voxel-dimensions 1×1×1.3mm), acquired in the coro-
al plane, along the hippocampal long-axis. The DT-MRI protocol
mployed single-shot spin-echo echo-planar diffusion-weighted
olumes (b=1000 smm−2) acquired in 64 non-collinear directions,
long with seven T2-weighted images (b=0 smm−2). Seventy-two
ontiguous axial slices of 2mmthicknesswere acquiredwith aﬁeld
f view of 256×256mm and matrix size of 128×128, giving a res-
lution of 2×2×2mm3. Repetition and echo timeswere 16.5 s and
5.5ms, respectively. Total image acquisition took approximately
0min.inology 62 (2015) 129–137 131
2.5. MRI analysis
Hippocampal volumes were initially segmented automatically
using FSL FIRST (T1W registered to an age-appropriate template;
Farrell et al., 2009) before visual assessment and manual editing by
one of the authors (NAR). The method was applied to all LBC1936
participants (see Aribisala et al., 2014 for example) with excellent
intra-rater reliability (ICC= .98 in a sample of 103; an example of
hippocampal segmentation is provided in Supplementary Fig. 1).
Automated segmentation of the hippocampus failed in one case,
leaving89participantswith availablehippocampal volumes (mm3)
corrected for intracranial volume. Intracranial volume, measured
by one of the authors (NAR), included all structures and CSF inside
the dura. The lower limit was the axial slice immediately inferior to
the inferior limit of the cerebellar tonsils on or above the superior
tipof theodontoidprocess (ValdésHernándezet al., 2012;Wardlaw
et al., 2011).
Two complementary methods to measure WM structure were
employed. Theﬁrst allows anestimate ofWMstructure by indexing
water molecule diffusion along major axonal ﬁbre bundles using
DT-MRI and tractography. The second quantiﬁes the total volume
of WMH—a common feature of the ageing brain, visible on T2- and
FLAIR-weighted MRI.
Probabilistic neighbourhood tractography (PNT) was used to
measure MD in twelve major long-range WM fasciculi: bilat-
eral anterior thalamic radiation, cingulum, uncinate, arcuate and
inferior longitudinal fasciculi, and the genu and splenium of the
corpus callosum. Initial pre-processing involved extracting the
brain, removing bulk participantmotion and eddy current-induced
distortions (by registering the component EPI data to the ﬁrst
T2-weighted volume), before water diffusion tensor parameters
were estimated using FSL tools (FMRIB, Oxford UK; www.fmrib.
ox.ac.uk). Brain connectivity data were created using the BED-
POSTX/ProbTrackX algorithm with a two-ﬁbre model and 5000
streamlines to reconstruct tracts of interest. PNT as implemented
in the TractoR package (http://www.tractor-mri.org.uk; Clayden
et al., 2011) was used to identify the tracts of interest from these
connectivity data. For each of the 12 fasciculi-of-interest, a seed
pointwas transferred fromthe centre of the reference tract (in stan-
dard space, derived from a digital white-matter atlas; Bastin et al.,
2010) into thenative spaceof thebrain to-be-analyzed.Around that
native space central seed point, a 7×7×7 volume is created from
which single seed point tractography is initiated. For each of the
343 voxels, the resulting ‘candidate’ tracts are compared against
the reference in terms of their length and shape. The one with
the closest match to the reference is then chosen; tract segmen-
tation was further improved by using the topological tract model
to reject false positive connections (Clayden et al., 2011). For each
tract in each participant, the seed point that produced the best
match to the reference tract was used to create the tractography
mask from which the tract-averaged MD values were calculated.
The resultant values for each tract were entered into a PCA and
extracted the ﬁrst unrotated component to derive a tract-averaged
score of general mean diffusivity (gMD) explaining 51.39% of the
variance (Cox et al., 2015; Penke et al., 2012). A measure of general
FA–similarly derived–is excluded from mediation analysis because
wepreviously reportedno signiﬁcant associationswith any cortisol
measures in this sample.
WMH were identiﬁed as punctate or diffuse areas that were
hyperintense compared to normal-appearing white and grey mat-
ter on T2-weighted and FLAIR images. Their volume was initially
quantiﬁed using the automated multi-spectral data fusion method
MCMxxVI (Valdés Hernández et al., 2010). Each segmentation was
then visually inspected and manually corrected for false-positives
and omissions.
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Mediator
(M)
Independent
(X)
Outcome
(Y)
a b
c'
Fig. 1. A schematic relationship in which an observed relationship between inde-
pendent (X) and outcome (Y) variables is hypothesised to be explained by amediator
variable M. The direct effect of X on M is a, the effect of M on Y is b, and c’ denotes
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Table 1
Descriptive statistics of study variables.
Variable units n Mean SD
WAKING nmol/l 89 24 10.59
EVENING nmol/l 84 3.47 2.75
DIURNAL nmol/l 84 −20.77 9.72
START nmol/l 86 16.39 7.77
END nmol/l 89 12.67 6.07
REACTIVE nmol/l 86 −3.87 7.19
MMSE /30 90 28.54 1.52
WMH mm3 89 12672.63 11037.29
HC mm3 89 3228.05 369.24
WAKING: salivary cortisol levels taken at home on waking, EVENING: salivary cor-
tisol levels taken at home at around 10 pm, DIURNAL: the slope (b–a) between
WAKING and EVENING, START: salivary cortisol levels taken at the start of a cogni-
tive testing appointment, END: salivary cortisol levels taken at the end of a cognitivehe X→Y path coefﬁcient after controlling for M. Therefore the indirect effect of X
n Y is the product of the X→M, and M→Y paths, or ab. For the purposes of this
tudy, X= cortisol, M=brain structure, Y= cognition.
.6. Statistical analysis
All data were examined for extreme values (±3 SD) and nor-
ality of distribution prior to knowledge of their relationships
ith other variables of interest. Extreme brain imaging valueswere
emoved if they clearly represented measurement error or partial
olume effects. Those that were found to be accurate were win-
orised in order to preserve meaningful data but minimise their
isproportionate effect on parametric statistics. A single marginal
utlier was identiﬁed in both left and right hippocampi; these
ere winsorised following examination of object maps by one of
he authors (NAR). Following examination of tract segmentation
uality (by SMM), tracts affected by partial volume averaging of
SF signal or those which contained aberrant or truncated path-
ays that were not anatomically plausible representations of the
asciculi of interestwere removed. Example of tracts deemed unac-
eptable are shown in Fig. 4 of Bastin et al. (2008). All outlying
ortisol data points (12; i.e. 3% of the total 360 samples) were
emoved since there is a weaker correspondence between salivary
nd serum cortisol with increasing concentrations (Hellhammer
t al., 2009). The outlying points were all higher than the 95th
ercentile of unpublished diurnal salivary cortisol data from up to
3,366 humans, collected at Dresden LabService GmbH, where the
ssays were undertaken (Clemens Kirschbaum, personal commu-
ication). A log transformation of cortisol measures at EVENING,
TART and END and a square root transformation of WMH volume
ormalised skewed distributions.
We then tested relationships between (1) cortisol levels and
ognitiveageingdifferences, (2)MRImeasures andcognitiveageing
ifferences, and (3) cortisol and MRI measures. Two-tailed Pear-
on’s product-moment correlations (r) are reported throughout.
ediation analysis was then used to examine the hypothesis that
oorer cognition is related to higher cortisol via the negative rela-
ionship between cortisol and MRI measures; in other words, brain
tructure signiﬁcantly mediates the negative relationship between
ortisol and cognition.
The most commonly-used mediation approach was proposed
y Baron and Kenny (1986) (Fig. 1). The causal steps strategy stipu-
ates that mediation is present if the X→Y relationship attenuates
o non-signiﬁcance when accounting for M, or that partial medi-
tion is present when the magnitude of X→Y is reduced after
. However, rather than concluding that mediation is present
hrough observation, we used the INDIRECT macro in IBM SPSS
9 (Preacher and Hayes, 2008) to assess mediation effects (the
ifference between X→Y and direct c’ effects) using 5000 boot-
trapped samples. This offers increased power over other methods,
uch as the Sobel test, because it makes no assumptions abouttesting appointment, REACTIVE: the slope (b–a) between START and END, MMSE:
Mini Mental State Examination scores, WMH: white matter hyperintensity volume,
HC: hippocampal volume.
distribution normality and guards against instances where the
change from signiﬁcance to non-signiﬁcance is accompanied by
a negligible decrease in coefﬁcient size (Type I error), or where a
large change in coefﬁcient size is accompanied by no ostensible
change in signiﬁcance (Type II error; Preacher and Hayes, 2004).
Based on the clearly directional hypotheses, one-tailed tests of
mediation were conducted (A. Hayes: http://www.afhayes.com/
macrofaq.html). Mediation effects are present if the conﬁdence
interval span does not include zero (Preacher and Hayes, 2008).
3. Results
3.1. Descriptive statistics
Descriptive statistics of salivary cortisol measures and MRI vari-
ables are provided in Table 1. Measures of general WM mean
diffusivity (gMD), general cognitive ability (g) and the domains of
processing speed (Speed) and Memory were all normalised residu-
alswith an approximatemean of 0 and a standard deviation of 1. As
previously reported, participants’ cortisol proﬁles generally exhib-
ited the expected pattern. WAKING levels were higher than in the
EVENING, START levels were higher than at END, and the majority
of participants’ START levels were higher or within 5nmol/l of the
value predicted by their linearly-modelled diurnal slope (Cox et al.,
2015).
3.2. Cortisol and cognitive ageing differences
Consistent with prior reports, age 11 IQ was a signiﬁcant pre-
dictor of g (r = .70, p< .001), speed (r = .45, p< .001) and memory
(r = .70, p< .001) in older age. Correlations between reactive and
diurnal cortisol and cognitive abilities (residualised for age 11 IQ)
are shown inTable 2.Higher STARTandENDcortisolwas associated
with poorer cognition across all measures (r=−.28 to −.36, p< .05).
However, neither WAKING, EVENING, nor either slope measure
(DIURNAL SLOPE or REACTIVE SLOPE) were signiﬁcantly associated
with measures of cognitive ageing differences. Given the highly
signiﬁcant correlation between START and END levels (r (84) = .45,
p< .001), and both levels being associated with cognition, we used
hierarchical linear regression to examine whether these cortisol
measures both contributed uniquely to the variance in cognitive
change. The result (Table 3) provides some evidence to support
this. Both START and END levels were signiﬁcant contributors to
MemoryR when entered together (R2 =18%). However, END only
showed a non-signiﬁcant trend when START was also included in
the SpeedR model (R2 =17%) and START levels did not contribute
signiﬁcantly when END was entered into the gfR model (R2 =13%).
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Table 2
Correlations among cortisol, cognitive ageing differences and brain MRI variables.
Salivary cortisol Cognition Brain MRI
Waking Eveninga Diurnal Starta Enda Reactive gfR SpeedR MemoryR Age 11 IQ gMD WMHb
1 WAKING
2 EVENINGa .21c
3 DIURNAL −.96f .04
4 STARTa −.04 .11 .05
5 ENDa −.01 −.04 .09 .45f
6 REACTIVE .09 −.18 −.00 −.67f .30e
7 gfR −.04 .05 −.02 -.28d −.36e .02
8 SpeedR −.06 .06 .02 −.36e −.35e .08 .72f
9 MemoryR −.00 −.07 −.07 −.35e −.36e .09 .68f .53f
10 Age 11 IQ .22d −.07 −.22c .03 .08 −.06 .00 .00 .00
11 gMD .07 .23c −.06 .25d −.11 −.39f −.25d −.34e −.28d .07
12 WMHb .04 .04 .01 .24d .21d −.11 −.10 −.28d −.25d .14 .27d
13 HC .10 .20c −.08 −.10 .05 .13 .35e .24d .23d .19 .03 .12
Shaded cells illustrate correlationswithinmeasurement-type, i.e. cortisol, cognition, and brain imaging; clear cells denote tests driven by experimental hypotheses.WAKING:
salivary cortisol levels taken at home on waking, EVENING: salivary cortisol levels taken at home at around 10 pm, DIURNAL: the slope (b–a) between WAKING and EVENING,
START: salivary cortisol levels taken at the start of a cognitive testing appointment, END: salivary cortisol levels taken at the end of a cognitive testing appointment, gf:
general cognitive ability, Speed: processing speed, Memory: memory ability, R: denotes that the variable was corrected for age 11 cognitive ability, gMD: general factor of
tract mean diffusivity, WMH: white matter hyperintensity volume, HC: hippocampal volume. Tract–speciﬁc relationships with cortisol are reported in Cox et al., 2015.
a Log transformed.
b Square root transformed.
c Trend (p< .08).
d p< .05.
e p< .01.
f p< .001.
Table 3
Hierarchical linear regression between cognitive change and reactive cortisol
measures.
ˇ1 ˇ2 F df R2 p
gf
+START −.28 6.47 1, 76 .08 .013
+START+END −.17a −.26 6.37 2, 75 .13 .005
Speed
+START −.36 11.18 1, 76 .13 <.001
+START+END −.27 −.21b 7.42 2, 75 .17 <.001
Memory
+START −.35 10.48 1, 76 .12 .002
+START+END −.24 −.26 8.03 2, 75 .18 <.001
All predictors were signiﬁcant (p< .05) apart from.
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We did not ﬁnd a signiﬁcant association between diurnal cor-a p= .158.
b p= .073.
.3. Cortisol and brain imaging variables
Correlations between cortisol levels and brain imaging mea-
ures are shown in Table 2. There were no signiﬁcant relationships
etween any cortisol measure and hippocampal volume. Aside
romanassociationbetweenhigher EVENINGandhigher gMD, there
ere no signiﬁcant relationships between diurnal cortisol and any
rain imaging variables. However, those with higher START corti-
ol levels had poorer WM structure (higher gMD or a greater WMH
olume). Higher END levels were also signiﬁcantly associated with
reater WMH volume. Contrary to expectations, a more steeply
egative REACTIVE SLOPE (denoting a greater decrease in corti-
ol levels between START and END) was associated with lower (i.e.
etter) gMD.
.4. Brain imaging variables and cognitive ageing differences
Correlations between brain imaging and cognitive variables
Table 2) were in the expected direction in every case (less cog-
itive change with larger hippocampal volume, lower WMH and
ower gMD). Thesewere signiﬁcant in every case (magnitudes raged
rom .23 to .35, p< .05) except for the relationship between gfR andWMH. Though REACTIVE SLOPE was related to gMD (Section 3.3), it
was not relevant to cognitive ageing differences.
3.5. Mediation analysis
Bootstrapping statistics were conducted on candidates for
mediation analysis, selected based on the presence of three-way
associations (cortisol–brain–cognition). Given the results of the
bivariate analyses above, mediation analyses involved START or
END cortisol measures as the independent (X) variable, gMD or
WMH as candidate mediators (M), and all three cognitive mea-
sures as outcome (Y) variables. Results of the analyses are shown
in Table 4. They indicate signiﬁcant mediation of the relation-
ship between cortisol and cognitive ageing differences by WM
measures in all but two instances (START→WMH→ gfR and
END→WMH→ gfR).
4. Discussion
In this study we found that cortisol levels measured at the start
and end of a cognitive test battery among older men were posi-
tively associated with a relative decline in general cognitive ability,
processing speed and memory functioning. Poorer WM structure
and smaller hippocampi were generally related to a greater rel-
ative decline in cognition. However, only measures of WM—not
hippocampal volume—were associated with elevated START and
END levels of cortisol. When formally tested using a bootstrap-
pingmethod, neuroradiologically complementarymeasures ofWM
microstructure (gMD) and macrostructure (WMH) showed signif-
icant partial mediation of cortisol–cognition relationships in 7
out of 9 candidate pathways. Taken together, these preliminary
and exploratory data support the hypothesis that reactive cortisol
measures are pertinent to life-course changes in cognitive ability,
partially through cortisol’s detrimental effects on WM structure,
but not via hippocampal volume.tisol values and older age cognition, in contrast with some – but
by no means all – cross-sectional studies in older adults. Some lon-
gitudinal studies do not implicate diurnal measures in cognitive
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Table 4
Mediation Analysis.
ˇ % Mediation model
X Y M c c’ Attenuation F (df) Lower CI Upper CI
STARTa gfR gMD −.34d −.29d 14.71 5.53 (2,67) −.2573 −.0071
STARTa gfR WMHb −.28c −.28c 0.00 3.20 (2,74) −.0748 .1030
STARTa SpeedR gMD −.42e −.36e 14.29 9.70 (2,67) −.3147 −.0254
STARTa SpeedR WMHb −.35d −.32d 8.57 6.53 (2,74) −.2665 −.0036
STARTa MemoryR gMD −.42e −.36d 14.29 8.40 (2,67) −.3178 −.0047
STARTa MemoryR WMHb −.35d −.31d 11.43 6.67 (2,74) −.2648 −.0005
ENDa gfR WMHb −.36d −.35d 2.78 5.60 (2,77) −.0890 .0562
ENDa SpeedR WMHb −.35d −.31d 11.43 7.08 (2,77) −.2203 −.0074
ENDa MemoryR WMHb −.36d −.33d 8.33 7.32 (2,76) −.2286 −.0013
X: independent variable, Y: outcome variable, M: mediator, c: path from X to Y (listwise, may differ slightly from pairwise associations reported in Table 2), c’: path from X
to Y accounting for M. Bold type face indicates signiﬁcant mediation effect (conﬁdence intervals do not include 0; Preacher and Hayes, 2008). START: cortisol levels at the
start of cognitive testing, END: cortisol levels at the end of cognitive testing, gf: general cognitive ability, speed: speed of processing, memory: memory ability, R: variable is
a residual, corrected for age 11 cognitive ability. All tests of mediation are one-tailed and bias-corrected.
a Log transformed.
b Square root transformed.
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hange (Seeman et al., 1997;MacLullich et al., 2012; Singh-Manoux
t al., 2014; but see also Li et al., 2006; Beluche et al., 2010). One
ould argue that the short follow up period in these studies (≤6
ears) may be too short to detect small effects reliably, but we ﬁnd
o indication of these effects on cognitive change over a period
f 60 years. Instead, we found that relationships with cognitive
geing differences were speciﬁc to salivary cortisol at the START
nd END of cognitive testing. Moreover, these two levels were
nly moderately correlated (.45), suggesting that not all individ-
als with high START levels necessarily have high END levels. The
ierarchical linear regression further suggests that both levels pro-
ide partially non-overlapping information about cognition (and
oth these cortisol measures and indices of cognition are related to
hitematter). Ourﬁndings accordwithother reported associations
etween greater reactive cortisol and poorer cognition in older age
MacLullich et al., 2005; Lee et al., 2007) and those linking elevated
ortisol or stress reactivity with poorer WM indices (MacRitchie
t al., 2013; Scheff and Cotman, 1982; Scheff and DeKosky, 1983).
The primarymechanism throughwhich cortisol has been linked
ith reduced white matter integrity is via the inhibition of repair
echanisms (Alonso, 2000; Miyata et al., 2011; Pires et al., 2015;
ajkowska and Miguel-Hidalgo, 2007; Scheff and Cotman, 1982;
cheff andDeKosky, 1983; van derWerff et al., 2014). As such, indi-
idual differences in HPA axis response to cognitive stressors may
nterfere with white matter repair following accumulated insult
ver the lifecourse, resulting in poorer integrity, impaired informa-
ion transfer between regions with increasing age, thus inﬂuencing
ognitive ageing differences. However, this study precludes direct
esting of cellular mechanisms, and little is currently known about
he test-retest reliability of reactive salivarymeasures (i.e. whether
hey measure a trait of biological response to challenge), which
ould beneﬁt from future investigation.
Our data are not consistent with a role for the hippocampus in
ortisol-related cognitive decline. Rodent models and early human
esearch supported the role of elevated GCs in ageing as a mech-
nism of hippocampal damage and memory impairment (Lupien
t al., 1998; Sapolsky et al., 1986). However, the present study is
ne of an increasing number to have found no association between
ippocampal volume and cortisol in older humans (Coluccia et al.,
008;Gold et al., 2005;Kremenet al., 2010a;MacLullich et al., 2005,
006, 2012), suggesting that hippocampal volume may not be the
rimary mediator of this association in healthy ageing. Neverthe-
ess, this does not exclude the possibility that the hippocampus is a
arget of deleterious GC-related change. Exposure to clinically highlevels inCushing’s disease results in reductionsof hippocampal vol-
ume (reviewed in Patil et al., 2007) but others report volumetric
reduction only in the head of the hippocampus (Toffanin et al., 2011
though the degree to which hippocampal atrophy in Cushing’s is
independent of global cerebral atrophy is unclear). Themore subtle
effects of non-pathological cortisol levels (such as those in healthy
ageing) on the hippocampus could be subregional and therefore
not detectable by gross volumetry. Some rodent studies have iden-
tiﬁed putative effects of GC exposure in areas CA1 and CA3 only
(reviewed inMcEwen, 2007). Although bothmineralocorticoid and
glucocorticoid receptors (GR) are found in the hippocampus (De
Kloet et al., 1998), GR may be less preferentially expressed in pri-
mates and humans than rodents in this region (Sanchéz et al.,
2000), potentially accounting for discrepancies between human
and rodent studies. Thus, takenwith other evidence, this study sug-
gests that the cortisol levels exhibited by relatively healthy older
adult humans may be insufﬁcient to cause detectable changes in
hippocampal volume.
We also note that WM measures only partially attenuated the
relationship between cortisol and cognitive change in our data.
What might account for the remainder of the variance? One pos-
sibility is that cortisol is related to the integrity of other brain
regions not reported. For example, the prefrontal cortex and amy-
dgala have both been implicated in HPA axis regulation and are
putative targets of cortisol-driven remodelling (e.g. Dedovic et al.,
2009). The brain’s WM and the hippocampus may also be affected
in ways that the current methods (diffusivity and volumetry) are
unable to detect. MRI-derived measures of longitudinal relaxation
time and magnetisation transfer ratio are promising alternative
indices of cerebral integrity (both exhibit stronger associations
with older-age cognition than volumetric indices in the hippocam-
pus; Aribisala et al., 2014). It is also possible that the magnitude
of cortisol–cognition mediation varies by white matter region or
tract; a question for which the current study lacks the requisite
statistical power. Thus, future studies could usefully examine the
cognitive correlates of cortisol proﬁles in relation to subregional
hippocampal volume, white matter tract–speciﬁc relationships,
other candidate brain regions, employing multi-modal MRI anal-
yses.
The present study has several limitations. The current mea-
sure of cognitive ageing differences from age 11 to 73 years is
inﬂuenced by periods of both neurodevelopment and neurode-
generation, which the current study is unable to parse apart. We
sampled salivary cortisol only once at each time point, though it
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as been recommended that at least two separate occasions are
referable for diurnal cortisol estimation (Kraemer et al., 2006).
n addition, we cannot know the level of adherence to the diurnal
ampling protocol. Though self-report from our participants and
ata from previous studies (Kraemer et al., 2006; Almeida et al.,
009) suggest we could expect high compliance, it is possible that
ur analysis with diurnal salivary cortisol variables are the sub-
ect of non-systematic noise from sampling error—a problem to
hich WAKING cortisol is particularly prone, given the complexi-
ies of the cortisol proﬁle in the ﬁrst hour post-waking (Fries et al.,
009). As such, interpretation of the diurnal cortisol samples, mea-
ured at home, should be interpreted advisedly. We did not take
easures of head motion during the scan. However, we adjusted
or this in the DT-MRI data, and visually examined tract, WMH
nd hippocampal segmentations (Section 2.5). Combined with the
act that participants in the current study are likely to represent
he more motivated (agreeing to participant in an additional study
omponent), probably healthier (based on the pre-selection crite-
ia outlined in Section 2), and thus more scan-tolerant members
f the cohort, will have greatly reduced the likelihood that move-
ent artefacts contributed signiﬁcant and non-trivial noise to our
nalyses. The temporal ordering of cognitive testing, cortisol sam-
ling and MRI scanning was not optimal, spanning over a year
n some cases. However, in the context of >60 years of cognitive
hange, between-subject differences in the lag between each stage
f data collection are relatively small within a group with a very
arrow age-range. Our sample is smaller than some other reports
e.g. Gerritsen et al., 2009; Comijs et al., 2010; Singh-Manoux et al.,
014; though they did not have MRI data), and the participants are
enerally healthy and are male, such that these results may not
xtrapolate to the general population. We also relied on commonly
mployedbehavioural cut-offs and the absence of clinical diagnosis
t initial recruitment to rule out pathological ageing as a potential
river of the reported effects (Section 2.1). The sample is also lim-
ted to healthy older males, precluding inference to older females.
lthough this design limits the generalizability of our ﬁndings, it
as the advantage of excluding the potential confounding effect of
ge and gender.
It could also be argued that the number of comparisons under-
aken requires Type I error correction. Table 2 illustrates the high
egree of shared variancewithinmeasurement types (shaded cells;
articularly so for cognitive and cortisol sampling measures), sug-
esting that correction may be overly conservative because each
est is not an entirely independent opportunity for Type I error
Ott, 1999; Nyholt, 2001). Moreover, identifying 9 mediation can-
idates which satisfy the 3-way signiﬁcance and directionality
peciﬁed by the hypothesis (and that they are broadly consistent
cross two neuroradiologically distinct measures of white matter)
s unlikely to be attributable to chance. Nevertheless, if our results
re re-considered with a more stringent threshold of p< .01, no
ssociations between brain and cortisol survive, leaving no can-
idates for mediation analysis and suggesting that these results
hould be interpreted with caution. Thus, in this exploratory anal-
sis, it is possible that some of the reported ﬁndings are due to Type
error.
Finally, mediation analysis is asymmetric because a non-
igniﬁcant ﬁnding can be seen as model falsiﬁcation, but a
igniﬁcant ﬁnding in mediation analysis only suggests support for
he proposed hypothesis, though it may also be consistent with
ther models (Penke and Deary, 2010; Salthouse, 2011) and does
ot rule out alternative conﬁgurations of causation between these
hree variable types (so-called speciﬁcation error). For example, in
simple mediation model, it is possible that all three variables are
nter-correlated because they are reﬂections of a single common
actor, or that there is an alternative causal direction. Thus, our
ndings could be explained because less cognitive decline reducesinology 62 (2015) 129–137 135
exposure to other factors that negatively affect WM and cogni-
tive ability. Poorer WM integrity could then impair supra-HPA axis
regulation during stressful situations, leading to elevated corti-
sol levels as a by-product. The current study lacks the power to
model the subtle interplay among a large number of potentially
confounding variables reliably (model parsimony is encouraged in
small samples, e.g. Penke andDeary, 2010), and neither cortisol nor
MRI measures were longitudinal. In future, well-powered longitu-
dinal studies could examine cortisol–brain–cognition relationships
in light of other factors which may affect brain ageing, such as dia-
betes (DiDalmazi et al., 2012), vascular risk (Verhaaren et al., 2013),
smoking and obesity (Debette et al., 2011) and physical activity
(Gow et al., 2012) in order to ascertain more reliably the unique
contribution that cortisol may make to brain and cognitive ageing.
In conclusion, the present study offers a novel perspective on
covariances among cognitive change, cortisol levels and brainmea-
sures in older age. Results of a formal test of statistical mediation
are in line with the hypothesis that brain WM structural integrity,
but not hippocampal volume, mediates the relationship between
elevated reactive cortisol and a relative decline in cognitive abil-
ity. Replications in larger cohorts which can more reliably detect
smaller effect sizes are required to properly assess the unique
contribution of cortisol to brain and cognitive ageing. The use of
multi-modalMRI and focus onother potential cerebral sites beyond
the hippocampus (Kremen et al., 2010b) and major WM tracts
would also improve our understanding of the interplay between
cortisol, the brain and cognition. The current ﬁndings may also
be relevant to future studies in stress-related hypercortisolemic
neuropsychiatric disorders.
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